根据名称进行药物检索

Promacot与迟发性运动障碍

Promacot与迟发性运动障碍安全配伍检测的结果。

检测结果:

Promacot <> 迟发性运动障碍

现实性: 23.07.2019 评论家: 医学副博士Shkutko P.M., in

通过权威的信息来源 Drugs.com、Rxlist.com、Webmd.com、Medscape.com，在进行所选药物与这种伴发疾病互相作用检测时，发现一些会产生负面影响或对身体危害的禁忌症及副作用。

用户:

吩噻可能常沉淀物的症状迟发运动障碍(TD)，一个综合症组成的节奏非自愿流动行各种涉及舌头上，脸上，嘴，嘴唇，下巴，和/或干和四肢，以下慢性使用至少几个月，但经常年。老年患者，特别是妇女，最容易受到影响。此外，丙基哌嗪衍生物样氟奋乃静、奋乃静、氯丙嗪和三氟拉嗪更有可能促使这种综合症。这两种风险的发展中TD和可能性，它将成为不可逆转的增加的持续时间和累积总剂量的吩治疗给药。然而，患者可以不经常出现症状之后相对较短处理时间在低剂量。如果TD期间发生的吩治疗、迅速撤出犯罪代理人或至少有一个降低的剂量应该加以考虑。 TD症状的人通常变得更加严重的后停药或用量减少，但是可以逐渐提高了几个月到几年。在患有先前存在的药物诱发的TD、发起或增加剂量的吩疗法可能会暂时掩蔽症状TD但最终可能会恶化的情况。较新的、非典型的神经抑制剂(例如，利培酮、硫平、奥氮平)往往是相关的一个基本上降低风险的诱导TD并被视为首选的药物的患者正在接受治疗的精神病。

来源

Oyewumi LK, Lapierre YD, Gray R, Batth S, Gelfand R "Abnormal involuntary movements in patients on long-acting neuroleptics." Prog Neuropsychopharmacol Biol Psychiatry 7 (1983): 719-23
Schwinghammer TL, Kroboth FJ, Juhl RP "Extrapyramidal reaction secondary to oral promethazine." Clin Pharm 3 (1984): 83-5
"Product Information. Sparine (promazine)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
Yesavage JA, Tanke ED, Sheikh JI "Tardive dyskinesia and steady-state serum levels of thiothixene." Arch Gen Psychiatry 44 (1987): 913-5
Boston Collaborative Drug Surveillance Program "Drug-induced extrapyramidal symptoms." JAMA 224 (1973): 889-91
"Product Information. Prolixin (fluphenazine)." Bristol-Myers Squibb, Princeton, NJ.
Sheppard C, Merlis S "Drug-induced extrapyramidal symptoms: their incidence and treatment." Am J Psychiatry 123 (1967): 886-9
"Product Information. Torecan (thiethylperazine)" Roxane Laboratories Inc, Columbus, OH.
"Product Information. Serentil (mesoridazine)" Boehringer-Ingelheim, Ridgefield, CT.
DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM "Pharmacotherapy: A Pathophysiologic Approach 4th" Stamford, CT: Appleton & Lange (1999):
"Product Information. Vesprin (triflupromazine)" Bristol-Myers Squibb, Princeton, NJ.
Mariani P "Adverse reactions to chlorpromazine in the treatment of migraine." Ann Emerg Med 17 (1988): 380-1
"Product Information. Tacaryl (methdilazine)." Westwood Squibb Pharmaceutical Corporation, Buffalo, NY.
Perenyi A, Arato M "Fluphenazine and tardive dyskinesia" Arch Gen Psychiatry 41 (1984): 727
"Product Information. Stelazine (trifluoperazine)" SmithKline Beecham, Philadelphia, PA.
Marcotte DB "Neuroleptics and neurologic reactions." South Med J 66 (1973): 321-4
McClelland HA, Metcalfe AV, Kerr TA, Dutta D, Watson P "Facial dyskinesia: a 16-year follow-up study" Br J Psychiatry 158 (1991): 691-6
"Product Information. Mellaril (thioridazine)." Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
Glazer WM, Moore DC "The diagnosis of rapid abnormal involuntary movements associated with fluphenazine decanoate." J Nerv Ment Dis 168 (1980): 439-41
Mukherjee S, Rosen AM, Cardenas C, Varia V, Olarte S "Tardive dyskinesia in psychiatric outpatients: a study of prevalence and association with demographic, clinical, and drug history variables." Arch Gen Psychiatry 39 (1982): 466-9
"Product Information. Thorazine (chlorpromazine)." SmithKline Beecham, Philadelphia, PA.
Kolakowska T, Williams AO, Ardern M "Tardive dyskinesia and current dose of neuroleptic drugs" Arch Gen Psychiatry 42 (1985): 925
"Product Information. Temaril (trimeprazine)" Allergan Inc, Irvine, CA.
Csernansky JG, Grabowski K, Cervantes J, Kaplan J, Yesavage JA "Fluphenazine decanoate and tardive dyskinesia: a possible association." Am J Psychiatry 138 (1981): 1362-5
Yassa R, Iskandar H, Ally J "The prevalence of tardive dyskinesia in fluphenazine-treated patients." J Clin Psychopharmacol 8 (1988): 17S-20S
Baker FM, Cook P "Compazine complications: a review." J Natl Med Assoc 73 (1981): 409-12
"Product Information. Compazine (prochlorperazine)." SmithKline Beecham, Philadelphia, PA.
"Product Information. Trilafon (perphenazine)" Schering Corporation, Kenilworth, NJ.
Curson DA, Barnes TR, Bamber RW, Platt SD, Hirsch SR, Duffy JC "Long-term depot maintenance of chronic schizophrenic out-patients: the seven year follow-up of the Medical Research Council fluphenazine/placebo trial. II. The incidence of compliance problems,side-effects, neurotic symptoms and depression" Br J Psychiatry 146 (1985): 469-74
Yassa R, Dimitry R "Single phenothiazines and tardive dyskinesia." J Clin Psychiatry 44 (1983): 233-4